89466-60-4

Basic information

• Product Name: 5-amino-1-(2-chloroethyl)-1H-pyrazole-4-carbonitrile
• CAS NO: 89466-60-4
• Molecular Formula: C₆H₇ClN₄
• Molecular Weight: 170.5996
• Mol File: 89466-60-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 378.5°C at 760 mmHg
• Flash Point: 182.7°C
• Density: 1.43g/cm³
• Vapor Pressure: 6.26E-06mmHg at 25°C
• Refractive Index: 1.644
• CAS DataBase Reference: 5-amino-1-(2-chloroethyl)-1H-pyrazole-4-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-amino-1-(2-chloroethyl)-1H-pyrazole-4-carbonitrile(89466-60-4)
• EPA Substance Registry System: 5-amino-1-(2-chloroethyl)-1H-pyrazole-4-carbonitrile(89466-60-4)

Safety Data

• Hazardous Substances Data: 89466-60-4(Hazardous Substances Data)

Upstream product

• 5346-53-2 5-amino-4-cyano-1-(2-hydroxyethyl)-pyrazole 

Downstream Products

• 99228-09-8 5-(1-Oxo-6-(2-propenyl)-2-cyclohexen-3-yl)amino-1-(2-chloroethyl)-4-cyanopyrazole 
• 1361960-72-6 6-(difluro-(4-fluorophenyl)methyl)-N-(5-methyl-1H-pyrazol-3-yl)-1-(2-morpholinoethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1361961-41-2 1-(2-chloroethyl)-6-(difluro-(4-fluorophenyl)-methyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ol 
• 1361960-73-7 6-(difluro-(4-fluorophenyl)methyl)-N-(5-methyl-1H-pyrazol-3-yl)-1-vinyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1361961-43-4 1-(2-chloroethyl)-6-(difluro-(4-fluorophenyl)methyl)-N-(5-methyl-1H-pyrazol-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 

Relevant articles and documents

AZOLOPYRIDINE AND AZOLOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are azolopyridine and azolopyrimidine compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

Pyrazolopyridine cycloalkanones and process for their preparation

Novel tetrahydropyrazolo-[3,4-b]quinolinones, cyclopenta[b]pyrazolo-[4,3-e]pyridinones and cyclohepta[b]-pyrazolo[4,3-e]pyridinones, useful as anxiolytics having reduced side effects, are disclosed, including methods of preparation, pharmaceutical compositions containing them and intermediates used in their preparation.